Discover 658 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 658
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Franklin WI, Evanston IL, Chicago IL, Naperville IL,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for
Congenital Adrenal Hyperplasia,
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Rochester MN,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144163
Phase 3, Recruiting
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
for
Keratitis, Corneal Ulcer
Location: Milwaukee WI, Oshkosh WI, Indianapolis IN,
Sponsor: Peschke GmbH
Sex: All
Age: 18+
Code: NCT05255107
Phase 2, Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Cudahy WI, Winfield IL, Palos Hills IL, Munster IN,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
Peri-neural Electrical Dry Needling Migraine Treatment Study
for
Migraine Headache
Location: Milwaukee WI
Sponsor: Wheaton Franciscan Healthcare
Sex: All
Age: 18 - 70+
Code: NCT04252391
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Effects of One Day of Activity on the Next Day's Exercise Response
for
Inactivity, Physical
Location: Mequon WI
Sponsor: Concordia University Wisconsin
Sex: All
Age: 18 - 30
Code: NCT07429370
Recruiting
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
for
Relapsed/Refractory Follicular Lymphoma,
Location: Waukesha WI, Indianapolis IN, Stony Brook NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06149286
Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Waukesha WI, Mukwonago WI, Oconomowoc WI, Grayslake IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase 3, Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Waukesha WI, Mukwonago WI, Oconomowoc WI, Grayslake IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07391774
Phase 3, Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Waukesha WI, Mukwonago WI, Oconomowoc WI, Madison WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase 3, Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Waukesha WI, Mukwonago WI, Oconomowoc WI, Grayslake IL,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase 3, Recruiting
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
for
Metastatic Nasopharyngeal Carcinoma,
Location: Waukesha WI, Mukwonago WI, Oconomowoc WI, Grayslake IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06029270
Phase 2, Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation